The new generation of weight-loss drugs are a boon for the overweight, but they also promise to change our relationship with ...

Novel drug delivery approach that utilizes long-acting injectable microcrystals may enable new options for long-term delivery of contraceptives.

Primary investigator and presenter of the study, Ahmed H. Zedan, MD, PhD from Lillebaelt Hospital - University Hospital of Southern Denmark said: ”Proclarix can be safely used to reduce performed ...

OMNIVISION, a leading global developer of semiconductor technology, including advanced digital imaging, analog, and display solutions, and Biotech Dental, a specialist in the design and manufacture of ...

Treatment with UBX1325 resulted in vision gains comparable to aflibercept at weeks 24 and 36 in difficult-to-treat patient population UBX1325 was non-inferior to aflibercept at week 24 (>90% confidenc ...

Company to Demonstrate Latest Advancements in Causal Machine Learning and AI for Trial Design and Predictive Analysis for Clinical Trial Success</ ...

UNITY anticipates the complete 36-week data results of the remaining patients in the second quarter of 2025.

As graduate programs lose spots and labs face shutdowns following Trump administration cuts to science funding, students and ...

Leuven, Belgium-based Augustine Therapeutics NV, a biotechnology company, has secured €77.7M in an oversubscribed Series A funding round co-led by Novo ...

Halia won the award for its work with HT-6184, an inflammasome inhibitor that targets inflammation associated with obesity, metabolic dysfunction, and other related diseases.

Candidates who took the Joint Admission Test for master's can download their scorecards from the official website.